Featured article: Clinical evaluation of a newly developed automated hemodialysis system as a clinical trial.
This study confirmed the safety and effectiveness of an automated hemodialysis system based on a central dialysate delivery system.
Featured article: Effects of hydrophilic polymer-coated polysulfone membrane dialyzers on intradialytic hypotension in diabetic hemodialysis patients (ATHRITE BP Study): a pilot study
The authors investigated whether “biocompatible” hydrophilic polymer-coated polysulfone dialyzers improve intradialytic hypotension in hemodialysis patients with diabetic nephropathy compared as conventional polysulfone/polyethersulfone dialyzers. In addition, to analyze the effects of “biocompatible” dialyzers on intradialytic hypotension, the authors also evaluated clinical and serological parameters of anemia, mineral-bone disorder, nutritional status, lipid profile, arteriosclerosis, and inflammation.
Featured article: Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial
This trial demonstrated the efficacy and safety of nalfurafine against refractory pruritus in peritoneal dialysis, suggesting clinical benefit for treating pruritus in peritoneal dialysis patients.
The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama
ISN Frontiers Meeting : Kidney Disease and Cardiovascular Disease
22-25 February 2018, Tokyo, KEIO Plaza Hotel
The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
30 November - 1 December 2019, Hiroshima International Conference Center
The 29th Annual Meeting of the Japan Society for Blood Purification Critical Care
19 - 20 October 2018, WINC Aichi
The 30th Annual Meeting of the Japan Society for Blood Purification Critical Care
26-27 October 2019, Hamamatsu ACT
The 9th Annual Meeting of the Japanese Society of Renal Rehabilitation
9-10 March 2019, B-ConPlaza (Beppu Convention Center)
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.
The Japanese Society for Clinical Renal Transplantation (JSCRT) was founded in 1969 on the vision of promoting the advancement of the science and practice of renal transplantation. JSCRT has expanded to include nearly 1,500 renal transplant professionals, including surgeons, physicians, pediatrician, nurses, coordinators, social workers, pharmacists, and dieticians. JSCRT is also dedicated to educating renal transplant professionals, to promoting research, and to advocating the highest quality care for patients.
The Japanese Society for Peritoneal Dialysis (JSPD) aims to contribute to the advancement of medicine and medical practice, the development of academic culture and people’s welfare through implementing programs for advancement, development and propagation of medical practice and research regarding renal failure and peritoneal dialysis therapies for people all over Japan. JSPD was established in 1995, and has currently 1,500 members.
The Japan Society for Blood Purification in Critical Care was founded in 1990 and aims to further the development and establishment of acute blood purification, such as continuous renal replacement therapy (CRRT). JSBPCC comprises nephrologists, emergency/critical care physicians, as well as clinical engineers and nurses mainly working in intensive care units (ICU). JSBPCC is dedicated to the development of safe and effective blood purification therapy for saving the lives of critically ill patients.
The Japanese Society of Renal Rehabilitation (JERR) promotes the progress and disseminate of the knowledge of renal rehabilitation through the presentation of papers on theoretical studies of nephrology, comprehensive rehabilitation and its practical applications, exchange of knowledge, encouragement of continuing education for members, enhancement of mutual coordination and cooperation of members and also related domestic and foreign societies. JSRR was established in 2011, and has currently 640 members and 75 facilities.
About the Editor
Prof Takashi Shigematsu, Editor-in-Chief
Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.